Medx Health

Medx Health FCF Yield

The Free Cash Flow Yield of Medx Health (MDX.V) as of Oct 19, 2026 is -20.69 %. In the previous year, Free Cash Flow Yield was -13.92 % — a change of 48.64% (lower).

FCF Yield

-20.69 %

YoY

48.64%

Last updated:

Free Cash Flow Yield of Medx Health is 2025 -20.69 % . Free Cash Flow Yield of Medx Health was 2024 -13.92 % . It decreases by 48.64% lower compared to the previous year.

The Medx Health FCF Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Yield
Date
FCF Yield
Jan 1, 2018
-14.51 CAD
Jan 1, 2019
-7.37 CAD
Jan 1, 2020
-16.16 CAD
Jan 1, 2021
-25.13 CAD
Jan 1, 2022
-15.53 CAD
Jan 1, 2023
-18.97 CAD
Jan 1, 2024
-13.92 CAD
Jan 1, 2025
-20.69 CAD
The Medx Health FCF Yield history
YEARFCF YieldYoY
-20.69 %+48.64%
-13.92 %-26.63%
-18.97 %+22.18%
-15.53 %-38.22%
-25.13 %+55.55%
-16.16 %+119.25%
-7.37 %-49.22%
-14.51 %+77.79%
-8.16 %+10.27%
-7.40 %+146.67%
-3.00 %-40.86%
-5.07 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Medx Health Stock analysis

What does Medx Health do? Medx Health Corp, trading under the ticker MDX.V, is a Canadian company headquartered in Mississauga, Ontario. The company went public on February 12, 2008, and operates within the Health Care sector, specifically in the Health Care industry. Medx Health Corp develops, manufactures, and sells medical devices and software. Its primary focus is on skin health, utilizing SIAscopy technology for skin-related screening tools. The company offers a telemedicine platform called SIAscopy on DermSecure, which integrates its SIAscopy scanning technology for web-based operations. Products include SIAMETRICS, SIMSYS, and MoleMate, which are hand-held devices that use light-based technology to examine moles and lesions up to two millimeters beneath the skin surface in a pain-free, non-invasive manner. These devices are designed for the rehabilitation market, providing phototherapy treatments using low-level laser and light-emitting diode technology to address pain and tissue damage. The company's offerings are centered around non-invasive skin screening and phototherapeutic applications, targeting both diagnostic and therapeutic needs within the health care sector. Medx Health Corp's products are intended for medical professionals and patients seeking advanced, non-invasive solutions for skin health management and rehabilitation. Medx Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medx Health stock

Free Cash Flow Yield of Medx Health is -20.69 % in 2025.

Free Cash Flow Yield of Medx Health changed from -13.92 % to -20.69 %, representing a 48.64% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield Medx Health since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's Medx Health with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Medx Health

All Key Metrics — Medx Health